Registered entities
Neurosense Therapeutics Ltd.
Reg. No. 6329140United States
Innovation
3 patent families (3 granted) — focus: Human necessities; filing pace steady. Cited 147 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 13.4K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Recent activity
18 Jun 2026
Event
BIO 2026
18 Mar 2026
Event
AD/PDTM 2026 Conference